Post by Healthcare Denmark

📈 Giving patients access to innovative medicines while spending healthcare resources responsibly – it's the balancing act every country is trying to get right. Which is exactly why knowledge sharing across nations is more important than ever. 🇨🇳 Chinese healthcare officials came to Denmark to do exactly that 🇩🇰 They saw digital health in practice at a Danish GP clinic. They heard how Denmark navigates procurement, pricing, and access – and how it anchors these challenges in a national #LifeScienceStrategy, where access to innovation is an explicit political ambition. And at a China–Denmark Health Conference, that exchange deepened with officials from China's National Healthcare Security Administration in dialogue with Amgros, Ministry of Health, Danish Medicine Agency, Ministry of Foreign Affairs, Novo Nordisk, Lundbeck, Coloplast, LEO Pharma, and ALK on procurement reform and patient access under China's 15th Five-Year Plan. Different systems. Shared challenges. That's why this dialogue matters 🌍🤝 Thanks to everyone who contributed to this important agenda. #LifeScience #HealthcareAccess #DigitalHealth #ChinaDenmark Lundbeck | Tina Hjortlund | Lene Qvist Larsen | Amgros I/S | Flemming Sonne | Coloplast | Kristian Teglkamp Flemmingson | Frederik Blom Andersen | ALK | Sarah Buchs | Victor Malecki | LEO Pharma | Klaus L. | Lisa Elliott | Novo Nordisk | Christian Juul Nyhus | Elliot Hughes | Sundheds- og Kirkeministeriet | Hanne Findsen | Lægemiddelstyrelsen (Danish Medicines Agency) | Kim Helleberg Madsen | Denmark in China | Martin William Behbahani | Thomas Aru | Ida Kok Rasmussen | Jakob Skaarup Nielsen